The psychological benefits of neuropsychological assessment feedback as a psycho-educational therapeutic intervention: A randomized-controlled trial with cross-over in multiple sclerosis.
Neuropsychol Rehabil
; 33(5): 764-793, 2023 Jun.
Article
em En
| MEDLINE
| ID: mdl-35332853
ABSTRACT
ABSTRACTEvidence supporting the direct therapeutic benefits of neuropsychological assessment (NPA) feedback relies mostly upon post-feedback consumer surveys. This randomized-controlled trial with cross-over investigated the benefits of NPA feedback in multiple sclerosis (MS). Seventy-one participants were randomly allocated to NPA with feedback or a "delayed-treatment" control group. The primary hypotheses were that NPA feedback would lead to improved knowledge of cognitive functioning and improved coping. Outcome instruments were administered by a research assistant blinded to group allocation. At 1-week post-NPA feedback there were no significant group-by-time interaction effects, indicating no improvement. But nor was there any significant deterioration in psychological wellbeing, despite most participants receiving "bad news" confirming cognitive impairment. At 1-month follow-up, within-subjects' analyses not only found no evidence of any delayed deterioration, but showed clinically significant improvement (small-medium effects) in perceived everyday cognitive functioning, MS self-efficacy, stress and depression. Despite lack of improvement in the RCT component at 1-week post-NPA feedback, the absence of deterioration at this time, in addition to significant improvements in perceived cognitive functioning, self-efficacy and mood at follow-up, together with high satisfaction ratings, all support NPA feedback as a safe psycho-educational intervention that is followed by improved psychological wellbeing over time.Trial registration Uniform Trial Number identifier U1111-1127-1585.Trial registration Australian New Zealand Clinical Trials Registry identifier ACTRN12612000161820.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Disfunção Cognitiva
/
Esclerose Múltipla
Tipo de estudo:
Clinical_trials
Limite:
Humans
País/Região como assunto:
Oceania
Idioma:
En
Revista:
Neuropsychol Rehabil
Assunto da revista:
NEUROLOGIA
/
PSICOLOGIA
/
REABILITACAO
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Austrália